awacke1/LOINC-Clinical-Terminology · Datasets at Hugging Face

LOINC_NUM stringlengths 3 8	COMPONENT stringlengths 2 246	PROPERTY stringlengths 1 29	TIME_ASPCT stringlengths 1 15	SYSTEM stringlengths 1 106	SCALE_TYP stringclasses 10 values	METHOD_TYP stringlengths 1 57 ⌀	CLASS stringlengths 2 24	CLASSTYPE int64 1 4	LONG_COMMON_NAME stringlengths 3 254	SHORTNAME stringlengths 2 51 ⌀	EXTERNAL_COPYRIGHT_NOTICE stringlengths 39 2.6k ⌀	STATUS stringclasses 4 values	VersionFirstReleased stringlengths 1 7	VersionLastChanged stringlengths 1 5
99072-1	Kelch-like protein 11 Ab.IgG	PrThr	Pt	Ser	Ord	CBA IFA	SERO	1	Kelch-like protein 11 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay	KLHL11 IgG Ser Ql CBA IFA	null	ACTIVE	2.72	2.72
99073-9	Kelch-like protein 11 Ab.IgG	PrThr	Pt	CSF	Ord	CBA IFA	SERO	1	Kelch-like protein 11 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay	KLHL11 IgG CSF Ql CBA IFA	null	ACTIVE	2.72	2.72
99074-7	Calcium/Creatinine	MRto	Pt	Urine^Fetus	Qn	null	CHEM	1	Calcium/Creatinine [Mass Ratio] in Urine from Fetus	Calcium/Creat Ur Fetus	null	ACTIVE	2.72	2.72
99075-4	Alpha-1-Microglobulin/Creatinine	MRto	24H	Urine	Qn	null	CHEM	1	Alpha-1-Microglobulin/Creatinine [Mass Ratio] in 24 hour Urine	A1 Microglob/Creat 24h Ur	null	ACTIVE	2.72	2.72
99076-2	Alpha-1-Microglobulin	MCnc	24H	Urine	Qn	null	CHEM	1	Alpha-1-Microglobulin [Mass/volume] in 24 hour Urine	A1 Microglob 24h Ur-mCnc	null	ACTIVE	2.72	2.72
9907-7	P wave duration.lead V1	Time	Pt	Heart	Qn	EKG	EKG.MEAS	2	P wave duration in lead V1	P wave dur L-V1	null	ACTIVE	1.0i	2.48
99077-0	Alpha-1-Fetoprotein.L3	MCnc	Pt	Ser/Plas	Qn	IA	CHEM	1	Alpha-1-Fetoprotein L3 [Mass/volume] in Serum or Plasma by Immunoassay	AFP L3 SerPl IA-mCnc	null	ACTIVE	2.72	2.72
99078-8	Thyrotropin blocking Ab	PrThr	Pt	Ser	Ord	CBA IFA	SERO	1	Thyrotropin blocking Ab [Presence] in Serum by Cell binding immunofluorescent assay	TSH Block Ab Ser Ql CBA IFA	null	ACTIVE	2.72	2.72
99079-6	Acrylfentanyl	PrThr	Pt	Urine	Ord	Confirm	DRUG/TOX	1	Acrylfentanyl [Presence] in Urine by Confirmatory method	Acrylfentanyl Ur Ql Cfm	null	ACTIVE	2.72	2.72
99080-4	O-Nortramadol	PrThr	Pt	Urine	Ord	Confirm	DRUG/TOX	1	O-nortramadol [Presence] in Urine by Confirmatory method	O-nortramadol Ur Ql Cfm	null	ACTIVE	2.72	2.72
99081-2	Furanylfentanyl	PrThr	Pt	Urine	Ord	Confirm	DRUG/TOX	1	Furanylfentanyl [Presence] in Urine by Confirmatory method	Furanylfentanyl Ur Ql Cfm	null	ACTIVE	2.72	2.72
99082-0	Coccidioides sp Ag	MCnc	Pt	Body fld	Qn	IA	MICRO	1	Coccidioides sp Ag [Mass/volume] in Body fluid by Immunoassay	Coccidioides Ag Fld IA-mCnc	null	ACTIVE	2.72	2.72
99083-8	Blastomyces sp Ag	MCnc	Pt	Body fld	Qn	IA	MICRO	1	Blastomyces sp Ag [Mass/volume] in Body fluid by Immunoassay	Blastomyces Ag Fld IA-mCnc	null	ACTIVE	2.72	2.73
99084-6	Aspergillus sp Ag	ACnc	Pt	Body fld	Qn	IA	MICRO	1	Aspergillus sp Ag [Units/volume] in Body fluid by Immunoassay	Aspergillus Ag Fld IA-aCnc	null	ACTIVE	2.72	2.72
9908-5	P wave duration.lead V2	Time	Pt	Heart	Qn	EKG	EKG.MEAS	2	P wave duration in lead V2	P wave dur L-V2	null	ACTIVE	1.0i	2.48
99085-3	Napsin A Ag	PrThr	Pt	Tiss	Ord	Immune stain	PATH	1	Napsin A Ag [Presence] in Tissue by Immune stain	Napsin A Ag Tiss Ql ImStn	null	ACTIVE	2.72	2.72
99086-1	p40 Ag	PrThr	Pt	Tiss	Ord	Immune stain	PATH	1	p40 Ag [Presence] in Tissue by Immune stain	p40 Ag Tiss Ql ImStn	null	ACTIVE	2.72	2.72
99087-9	Meningitis+Encephalitis pathogens panel	-	Pt	CSF	-	Probe.amp.tar	PANEL.MICRO	1	Meningitis+Encephalitis pathogens panel - Cerebral spinal fluid by NAA with probe detection	Mening+Enc Pnl CSF NAA+probe	null	ACTIVE	2.72	2.72
99088-7	Cryptococcus gattii+neoformans DNA	PrThr	Pt	CSF	Ord	Probe.amp.tar	MICRO	1	Cryptococcus gattii+neoformans DNA [Presence] in Cerebral spinal fluid by NAA with probe detection	C gattii+neofor DNA CSF Ql NAA+probe	null	ACTIVE	2.72	2.72
99089-5	Escherichia coli K1 DNA	PrThr	Pt	CSF	Ord	Probe.amp.tar	MICRO	1	Escherichia coli K1 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection	E coli K1 DNA CSF Ql NAA+probe	null	ACTIVE	2.72	2.72
99090-3	Haemophilus influenzae DNA	PrThr	Pt	CSF	Ord	Probe.amp.tar	MICRO	1	Haemophilus influenzae DNA [Presence] in Cerebral spinal fluid by NAA with probe detection	Haem influ DNA CSF Ql NAA+probe	null	ACTIVE	2.72	2.72
99091-1	Listeria monocytogenes DNA	PrThr	Pt	CSF	Ord	Probe.amp.tar	MICRO	1	Listeria monocytogenes DNA [Presence] in Cerebral spinal fluid by NAA with probe detection	L monocytog DNA CSF Ql NAA+probe	null	ACTIVE	2.72	2.72
99092-9	Neisseria meningitidis DNA	PrThr	Pt	CSF	Ord	Probe.amp.tar	MICRO	1	Neisseria meningitidis DNA [Presence] in Cerebral spinal fluid by NAA with probe detection	N men DNA CSF Ql NAA+probe	null	ACTIVE	2.72	2.72
9909-3	P wave duration.lead V3	Time	Pt	Heart	Qn	EKG	EKG.MEAS	2	P wave duration in lead V3	P wave dur L-V3	null	ACTIVE	1.0i	2.48
99093-7	Streptococcus agalactiae DNA	PrThr	Pt	CSF	Ord	Probe.amp.tar	MICRO	1	Streptococcus agalactiae DNA [Presence] in Cerebral spinal fluid by NAA with probe detection	Gp B Strep DNA CSF Ql NAA+probe	null	ACTIVE	2.72	2.72
99094-5	Streptococcus pneumoniae DNA	PrThr	Pt	CSF	Ord	Probe.amp.tar	MICRO	1	Streptococcus pneumoniae DNA [Presence] in Cerebral spinal fluid by NAA with probe detection	S pneum DNA CSF Ql NAA+probe	null	ACTIVE	2.72	2.72
99095-2	Streptococcus pyogenes DNA	PrThr	Pt	CSF	Ord	Probe.amp.tar	MICRO	1	Streptococcus pyogenes DNA [Presence] in Cerebral spinal fluid by NAA with probe detection	S pyo DNA CSF Ql NAA+probe	null	ACTIVE	2.72	2.72
99096-0	Mycoplasma pneumoniae DNA	PrThr	Pt	CSF	Ord	Probe.amp.tar	MICRO	1	Mycoplasma pneumoniae DNA [Presence] in Cerebral spinal fluid by NAA with probe detection	M pneumo DNA CSF Ql NAA+probe	null	ACTIVE	2.72	2.72
99097-8	Blastomyces dermatitidis Ab.IgG	ACnc	Pt	CSF	Qn	IA	MICRO	1	Blastomyces dermatitidis IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay	B dermat IgG CSF IA-aCnc	null	ACTIVE	2.72	2.72
99098-6	Blastomyces dermatitidis Ab.IgG	ACnc	Pt	Ser	Qn	IA	MICRO	1	Blastomyces dermatitidis IgG Ab [Units/volume] in Serum by Immunoassay	B dermat IgG Ser IA-aCnc	null	ACTIVE	2.72	2.72
99099-4	Procalcitonin	SCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Procalcitonin [Moles/volume] in Serum or Plasma	Procalcitonin SerPl-sCnc	null	ACTIVE	2.72	2.72
991-0	D little o super little a Ab	PrThr	Pt	Ser/Plas^BPU	Ord	null	BLDBK	1	Do sup(a) Ab [Presence] in Serum or Plasma from Blood product unit	Do sup(a) Ab SerPl BPU Ql	null	ACTIVE	1.0	2.56
99100-0	Norepinephrine	MCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Norepinephrine [Mass/volume] in Serum or Plasma	Norepineph SerPl-mCnc	null	ACTIVE	2.72	2.72
9910-1	P wave duration.lead V4	Time	Pt	Heart	Qn	EKG	EKG.MEAS	2	P wave duration in lead V4	P wave dur L-V4	null	ACTIVE	1.0i	2.48
99101-8	Cancer Ag 242	ACnc	Pt	Ser/Plas	Qn	null	CHEM	1	Cancer Ag 242 [Units/volume] in Serum or Plasma	Cancer Ag242 SerPl-aCnc	null	ACTIVE	2.72	2.72
99102-6	Gastrin releasing polypeptide	ACnc	Pt	Ser/Plas	Qn	null	CHEM	1	Gastrin releasing polypeptide [Units/volume] in Serum or Plasma	GRP SerPl-aCnc	null	ACTIVE	2.72	2.72
99103-4	Tumor necrosis factor.alpha	ACnc	Pt	Ser/Plas	Qn	null	CHEM	1	Tumor necrosis factor.alpha [Units/volume] in Serum or Plasma	A-Tumor Necrosis Fact SerPl-aCnc	null	ACTIVE	2.72	2.72
99104-2	Choriogonadotropin	MCnc	Pt	Urine	Qn	null	CHEM	1	Choriogonadotropin [Mass/volume] in Urine	HCG Ur-mCnc	null	ACTIVE	2.72	2.72
99105-9	Chlamydia trachomatis Ag	PrThr	Pt	Ser/Plas	Ord	IA	MICRO	1	Chlamydia trachomatis Ag [Presence] in Serum or Plasma by Immunoassay	C trach Ag SerPl Ql IA	null	ACTIVE	2.72	2.72
99106-7	How often do you attend meetings of the clubs or organizations you belong to	NRat	Pt	^Patient	Qn	null	SURVEY.NHANES	4	How often do you attend meetings of the clubs or organizations you belong to	null	null	ACTIVE	2.72	2.72
99107-5	Stimulants drug panel	-	Pt	Urine	-	Screen	PANEL.DRUG/TOX	1	Stimulants drug panel - Urine by Screen method	Stimulants drug panel Ur Scn	null	ACTIVE	2.72	2.72
99108-3	ePHEDrine	PrThr	Pt	Urine	Ord	Screen	DRUG/TOX	1	ePHEDrine [Presence] in Urine by Screen method	Ephedrin Ur Ql Scn	null	ACTIVE	2.72	2.72
99109-1	Pseudoephedrine	PrThr	Pt	Urine	Ord	Screen	DRUG/TOX	1	Pseudoephedrine [Presence] in Urine by Screen method	Pseudoephedrine Ur Ql Scn	null	ACTIVE	2.72	2.72
99110-9	Alpha-Phenyl-2-Piperidine acetate	PrThr	Pt	Urine	Ord	Screen	DRUG/TOX	1	Alpha-Phenyl-2-Piperidine acetate [Presence] in Urine by Screen method	PPAA Ur Ql Scn	null	ACTIVE	2.72	2.72
99111-7	Dengue virus Ab.Neut	Titr	Pt	XXX	Qn	Neut	MICRO	1	Dengue virus neutralizing antibody [Titer] in Specimen by Neutralization test	DENV NAb Titr Spec Nt	null	ACTIVE	2.72	2.72
99112-5	Rocio virus Ab.Neut	Titr	Pt	XXX	Qn	Neut	MICRO	1	Rocio virus neutralizing antibody [Titer] in Specimen by Neutralization test	Rocio virus NAb Titr Spec Nt	null	ACTIVE	2.72	2.72
99113-3	Ilheus virus Ab.Neut	Titr	Pt	XXX	Qn	Neut	MICRO	1	Ilheus virus neutralizing antibody [Titer] in Specimen by Neutralization test	ILHV NAb Titr Spec Nt	null	ACTIVE	2.72	2.72
99114-1	Semliki Forest virus Ab.Neut	Titr	Pt	XXX	Qn	Neut	MICRO	1	Semliki Forest virus neutralizing antibody [Titer] in Specimen by Neutralization test	SFV NAb Titr Spec Nt	null	ACTIVE	2.72	2.72
99115-8	Onyong-nyong virus Ab.Neut	Titr	Pt	XXX	Qn	Neut	MICRO	1	Onyong-nyong virus neutralizing antibody [Titer] in Specimen by Neutralization test	ONN virus NAb Titr Spec Nt	null	ACTIVE	2.72	2.72
99116-6	Bourbon virus Ab.Neut	Titr	Pt	XXX	Qn	Neut	MICRO	1	Bourbon virus neutralizing antibody [Titer] in Specimen by Neutralization test	Bourbon virus NAb Titr Spec Nt	null	ACTIVE	2.72	2.72
99117-4	Toscana virus Ab.Neut	Titr	Pt	XXX	Qn	Neut	MICRO	1	Toscana virus neutralizing antibody [Titer] in Specimen by Neutralization test	TOSV NAb Titr Spec Nt	null	ACTIVE	2.72	2.72
99118-2	Sandfly fever Sicilian virus Ab.Neut	Titr	Pt	XXX	Qn	Neut	MICRO	1	Sandfly fever Sicilian virus neutralizing antibody [Titer] in Specimen by Neutralization test	SFSV NAb Titr Spec Nt	null	ACTIVE	2.72	2.72
9911-9	P wave duration.lead V5	Time	Pt	Heart	Qn	EKG	EKG.MEAS	2	P wave duration in lead V5	P wave dur L-V5	null	ACTIVE	1.0i	2.48
99119-0	Sandfly fever Naples virus Ab.Neut	Titr	Pt	XXX	Qn	Neut	MICRO	1	Sandfly fever Naples virus neutralizing antibody [Titer] in Specimen by Neutralization test	SFNV NAb Titr Spec Nt	null	ACTIVE	2.72	2.72
99120-8	Oropouche virus Ab.Neut	Titr	Pt	XXX	Qn	Neut	MICRO	1	Oropouche virus neutralizing antibody [Titer] in Specimen by Neutralization test	Oropouche virus NAb Titr Spec Nt	null	ACTIVE	2.72	2.72
99121-6	Rift Valley fever virus Ab.Neut	Titr	Pt	XXX	Qn	Neut	MICRO	1	Rift valley fever virus neutralizing antibody [Titer] in Specimen by Neutralization test	RVFV NAb Titr Spec Nt	null	ACTIVE	2.72	2.72
99122-4	Bwamba virus Ab.Neut	Titr	Pt	XXX	Qn	Neut	MICRO	1	Bwamba virus neutralizing antibody [Titer] in Specimen by Neutralization test	Bwamba virus NAb Titr Spec Nt	null	ACTIVE	2.72	2.72
99123-2	Heartland banyangvirus Ab.Neut	Titr	Pt	XXX	Qn	Neut	MICRO	1	Heartland banyangvirus neutralizing antibody [Titer] in Specimen by Neutralization test	HRTV NAb Titr Spec Nt	null	ACTIVE	2.72	2.72
99124-0	Tick-borne encephalitis virus Ab.Neut	Titr	Pt	XXX	Qn	Neut	MICRO	1	Tick-borne encephalitis virus neutralizing antibody [Titer] in Specimen by Neutralization test	TBEV NAb Titr Spec Nt	null	ACTIVE	2.72	2.72
99125-7	Bunyamwera virus Ab.Neut	Titr	Pt	XXX	Qn	Neut	MICRO	1	Bunyamwera virus neutralizing antibody [Titer] in Specimen by Neutralization test	Bunyamwera virus NAb Titr Spec Nt	null	ACTIVE	2.72	2.72
99126-5	NOTCH1 gene targeted mutation analysis	Prid	Pt	Bld/Tiss	Nom	Molgen	MOLPATH.MUT	1	NOTCH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal	NOTCH1 Mut Anl Bld/T	null	ACTIVE	2.72	2.72
9912-7	P wave duration.lead V6	Time	Pt	Heart	Qn	EKG	EKG.MEAS	2	P wave duration in lead V6	P wave dur L-V6	null	ACTIVE	1.0i	2.48
99127-3	BIRC3 gene targeted mutation analysis	Prid	Pt	Bld/Tiss	Nom	Molgen	MOLPATH.MUT	1	BIRC3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal	BIRC3 gene Mut Anl Bld/T	null	ACTIVE	2.72	2.72
99128-1	PLCG2 gene targeted mutation analysis	Prid	Pt	Bld/Tiss	Nom	Molgen	MOLPATH.MUT	1	PLCG2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal	PLCG2 gene Mut Anl Bld/T	null	ACTIVE	2.72	2.72
99129-9	SF3B1 gene targeted mutation analysis	Prid	Pt	Bld/Tiss	Nom	Molgen	MOLPATH.MUT	1	SF3B1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal	SF3B1 gene Mut Anl Bld/T	null	ACTIVE	2.72	2.72
99130-7	Outcome and assessment information set (OASIS) form - version E	-	Pt	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	Outcome and assessment information set (OASIS) form - version E [CMS Assessment]	null	null	ACTIVE	2.72	2.72
99131-5	Outcome and assessment information set (OASIS) form - version E - Start of Care	-	Pt	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	Outcome and assessment information set (OASIS) form - version E - Start of Care [CMS Assessment]	null	null	ACTIVE	2.72	2.72
99132-3	OASIS E - Administrative information - SOC	-	Pt	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	OASIS E - Administrative information - SOC [CMS Assessment]	null	null	ACTIVE	2.72	2.72
99133-1	Near convergence break	InvLen	Pt	Eye	Qn	Phoropter	EYE.REFRACTION	2	Near convergence break by Phoropter	Near con break by Phoropter	null	ACTIVE	2.72	2.72
99134-9	You or your families' health is affected by environmental conditions at home	Find	Pt	^Patient	Ord	null	SURVEY.SDOH	4	You or your families' health is affected by environmental conditions at home	null	null	ACTIVE	2.72	2.72
9913-5	P' wave amplitude.lead AVF	Elpot	Pt	Heart	Qn	EKG	EKG.MEAS	2	P' wave amplitude in lead AVF	P' wave Amp L-AVF	null	ACTIVE	1.0i	2.48
99135-6	Environmental conditions in the home that affect you or your families' health	Find	Pt	^Patient	Nom	null	SURVEY.SDOH	4	Environmental conditions in the home that affect you or your families' health	null	null	ACTIVE	2.72	2.72
99136-4	Rabies virus Ab.IgM	Titr	Pt	XXX	Qn	IF	MICRO	1	Rabies virus IgM Ab [Titer] in Specimen by Immunofluorescence	RABV IgM Titr Spec IF	null	ACTIVE	2.72	2.72
99137-2	Rabies virus Ab.IgG	Titr	Pt	XXX	Qn	IF	MICRO	1	Rabies virus IgG Ab [Titer] in Specimen by Immunofluorescence	RABV IgG Titr Spec IF	null	ACTIVE	2.72	2.72
99138-0	OASIS E - Hearing, speech, and vision - SOC	-	Pt	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	OASIS E - Hearing, speech, and vision - SOC [CMS Assessment]	null	null	ACTIVE	2.72	2.72
99139-8	Sjogrens syndrome-A extractable nuclear 52kD Ab	ACnc	Pt	Ser	Qn	Line blot	SERO	1	Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum by Line blot	ENA SS-A 52kD Ab Ser Line blot-aCnc	null	ACTIVE	2.72	2.72
99140-6	OASIS E - Cognitive Patterns - SOC, ROC, DC	-	Pt	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	OASIS E - Cognitive Patterns - SOC, ROC, DC [CMS Assessment]	null	null	ACTIVE	2.72	2.72
99142-2	OASIS E - Health Conditions - SOC, ROC	-	Pt	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	OASIS E - Health Conditions - SOC, ROC [CMS Assessment]	null	null	ACTIVE	2.72	2.72
9914-3	P' wave amplitude.lead AVL	Elpot	Pt	Heart	Qn	EKG	EKG.MEAS	2	P' wave amplitude in lead AVL	P' wave Amp L-AVL	null	ACTIVE	1.0i	2.48
99143-0	OASIS E - Special Treatment, Procedures, and Programs - SOC	-	Pt	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	OASIS E - Special Treatment, Procedures, and Programs - SOC [CMS Assessment]	null	null	ACTIVE	2.72	2.72
99144-8	OASIS E - Behavior - SOC, ROC, DC	-	Pt	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	OASIS E - Behavior - SOC, ROC, DC [CMS Assessment]	null	null	ACTIVE	2.72	2.72
99146-3	OASIS E - Active Diagnoses - SOC	-	Pt	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	OASIS E - Active Diagnoses - SOC [CMS Assessment]	null	null	ACTIVE	2.72	2.72
99147-1	OASIS E - Preferences for Customary Routine Activities - SOC, ROC	-	Pt	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	OASIS E - Preferences for Customary Routine Activities - SOC, ROC [CMS Assessment]	null	null	ACTIVE	2.72	2.72
99148-9	OASIS E - Functional Status - SOC, ROC, DC	-	Pt	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	OASIS E - Functional Status - SOC, ROC, DC [CMS Assessment]	null	null	ACTIVE	2.72	2.72
99149-7	OASIS E - Self-care - follow-up performance	-	RptPeriod	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	OASIS E - Self-care - follow-up performance during assessment period [CMS Assessment]	null	null	ACTIVE	2.72	2.72
9915-0	P' wave amplitude.lead AVR	Elpot	Pt	Heart	Qn	EKG	EKG.MEAS	2	P' wave amplitude in lead AVR	P' wave Amp L-AVR	null	ACTIVE	1.0i	2.48
99150-5	OASIS E - Mobility - follow-up performance	-	RptPeriod	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	OASIS E - Mobility - follow-up performance during assessment period [CMS Assessment]	null	null	ACTIVE	2.72	2.72
99151-3	OASIS E - Medications - SOC, ROC	-	Pt	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	OASIS E - Medications - SOC, ROC [CMS Assessment]	null	null	ACTIVE	2.72	2.72
99152-1	OASIS E - Swallowing And Or Nutritional Status - SOC	-	Pt	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	OASIS E - Swallowing And Or Nutritional Status - SOC [CMS Assessment]	null	null	ACTIVE	2.72	2.72
99153-9	Outcome and assessment information set (OASIS) form - version E - Follow Up	-	Pt	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	Outcome and assessment information set (OASIS) form - version E - Follow Up [CMS Assessment]	null	null	ACTIVE	2.72	2.72
99154-7	OASIS E - Functional abilities and goals - FU	-	Pt	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	OASIS E - Functional abilities and goals - FU [CMS Assessment]	null	null	ACTIVE	2.72	2.72
99155-4	OASIS E - Functional Status - follow up	-	Pt	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	OASIS E - Functional Status - follow up [CMS Assessment]	null	null	ACTIVE	2.72	2.72
99156-2	OASIS E - Health Conditions - FU	-	Pt	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	OASIS E - Health Conditions - FU [CMS Assessment]	null	null	ACTIVE	2.72	2.72
99157-0	OASIS E - Skin Conditions - FU	-	Pt	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	OASIS E - Skin Conditions - FU [CMS Assessment]	null	null	ACTIVE	2.72	2.72
99158-8	Outcome and assessment information set (OASIS) form - version E - Death at Home	-	Pt	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	Outcome and assessment information set (OASIS) form - version E - Death at Home [CMS Assessment]	null	null	ACTIVE	2.72	2.72
99159-6	OASIS E - Administrative information - DAH	-	Pt	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	OASIS E - Administrative information - DAH [CMS Assessment]	null	null	ACTIVE	2.72	2.72
99160-4	Outcome and assessment information set (OASIS) form - version E - Resumption of Care	-	Pt	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	Outcome and assessment information set (OASIS) form - version E - Resumption of Care [CMS Assessment]	null	null	ACTIVE	2.72	2.72
99161-2	OASIS E - Administrative information - ROC	-	Pt	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	OASIS E - Administrative information - ROC [CMS Assessment]	null	null	ACTIVE	2.72	2.72
9916-8	P' wave amplitude.lead I	Elpot	Pt	Heart	Qn	EKG	EKG.MEAS	2	P' wave amplitude in lead I	P' wave Amp L-I	null	ACTIVE	1.0i	2.48
99169-5	OASIS E - Active Diagnoses - ROC	-	Pt	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	OASIS E - Active Diagnoses - ROC [CMS Assessment]	null	null	ACTIVE	2.72	2.72

99072-1

Kelch-like protein 11 Ab.IgG

PrThr

Pt

Ser

Ord

CBA IFA

SERO

1

Kelch-like protein 11 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay

KLHL11 IgG Ser Ql CBA IFA

null

ACTIVE

2.72

99073-9

Kelch-like protein 11 Ab.IgG

PrThr

Pt

CSF

Ord

CBA IFA

SERO

1

Kelch-like protein 11 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

KLHL11 IgG CSF Ql CBA IFA

null

ACTIVE

2.72

99074-7

Calcium/Creatinine

MRto

Pt

Urine^Fetus

Qn

null

CHEM

1

Calcium/Creatinine [Mass Ratio] in Urine from Fetus

Calcium/Creat Ur Fetus

null

ACTIVE

2.72

99075-4

Alpha-1-Microglobulin/Creatinine

MRto

24H

Urine

Qn

null

CHEM

1

Alpha-1-Microglobulin/Creatinine [Mass Ratio] in 24 hour Urine

A1 Microglob/Creat 24h Ur

null

ACTIVE

2.72

99076-2

Alpha-1-Microglobulin

MCnc

24H

Urine

Qn

null

CHEM

1

Alpha-1-Microglobulin [Mass/volume] in 24 hour Urine

A1 Microglob 24h Ur-mCnc

null

ACTIVE

2.72

9907-7

P wave duration.lead V1

Time

Pt

Heart

Qn

EKG

EKG.MEAS

2

P wave duration in lead V1

P wave dur L-V1

null

ACTIVE

1.0i

2.48

99077-0

Alpha-1-Fetoprotein.L3

MCnc

Pt

Ser/Plas

Qn

IA

CHEM

1

Alpha-1-Fetoprotein L3 [Mass/volume] in Serum or Plasma by Immunoassay

AFP L3 SerPl IA-mCnc

null

ACTIVE

2.72

99078-8

Thyrotropin blocking Ab

PrThr

Pt

Ser

Ord

CBA IFA

SERO

1

Thyrotropin blocking Ab [Presence] in Serum by Cell binding immunofluorescent assay

TSH Block Ab Ser Ql CBA IFA

null

ACTIVE

2.72

99079-6

Acrylfentanyl

PrThr

Pt

Urine

Ord

Confirm

DRUG/TOX

1

Acrylfentanyl [Presence] in Urine by Confirmatory method

Acrylfentanyl Ur Ql Cfm

null

ACTIVE

2.72

99080-4

O-Nortramadol

PrThr

Pt

Urine

Ord

Confirm

DRUG/TOX

1

O-nortramadol [Presence] in Urine by Confirmatory method

O-nortramadol Ur Ql Cfm

null

ACTIVE

2.72

99081-2

Furanylfentanyl

PrThr

Pt

Urine

Ord

Confirm

DRUG/TOX

1

Furanylfentanyl [Presence] in Urine by Confirmatory method

Furanylfentanyl Ur Ql Cfm

null

ACTIVE

2.72

99082-0

Coccidioides sp Ag

MCnc

Pt

Body fld

Qn

IA

MICRO

1

Coccidioides sp Ag [Mass/volume] in Body fluid by Immunoassay

Coccidioides Ag Fld IA-mCnc

null

ACTIVE

2.72

99083-8

Blastomyces sp Ag

MCnc

Pt

Body fld

Qn

IA

MICRO

1

Blastomyces sp Ag [Mass/volume] in Body fluid by Immunoassay

Blastomyces Ag Fld IA-mCnc

null

ACTIVE

2.72

2.73

99084-6

Aspergillus sp Ag

ACnc

Pt

Body fld

Qn

IA

MICRO

1

Aspergillus sp Ag [Units/volume] in Body fluid by Immunoassay

Aspergillus Ag Fld IA-aCnc

null

ACTIVE

2.72

9908-5

P wave duration.lead V2

Time

Pt

Heart

Qn

EKG

EKG.MEAS

2

P wave duration in lead V2

P wave dur L-V2

null

ACTIVE

1.0i

2.48

99085-3

Napsin A Ag

PrThr

Pt

Tiss

Ord

Immune stain

PATH

1

Napsin A Ag [Presence] in Tissue by Immune stain

Napsin A Ag Tiss Ql ImStn

null

ACTIVE

2.72

99086-1

p40 Ag

PrThr

Pt

Tiss

Ord

Immune stain

PATH

1

p40 Ag [Presence] in Tissue by Immune stain

p40 Ag Tiss Ql ImStn

null

ACTIVE

2.72

99087-9

Meningitis+Encephalitis pathogens panel

-

Pt

CSF

-

Probe.amp.tar

PANEL.MICRO

1

Meningitis+Encephalitis pathogens panel - Cerebral spinal fluid by NAA with probe detection

Mening+Enc Pnl CSF NAA+probe

null

ACTIVE

2.72

99088-7

Cryptococcus gattii+neoformans DNA

PrThr

Pt

CSF

Ord

Probe.amp.tar

MICRO

1

Cryptococcus gattii+neoformans DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

C gattii+neofor DNA CSF Ql NAA+probe

null

ACTIVE

2.72

99089-5

Escherichia coli K1 DNA

PrThr

Pt

CSF

Ord

Probe.amp.tar

MICRO

1

Escherichia coli K1 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

E coli K1 DNA CSF Ql NAA+probe

null

ACTIVE

2.72

99090-3

Haemophilus influenzae DNA

PrThr

Pt

CSF

Ord

Probe.amp.tar

MICRO

1

Haemophilus influenzae DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

Haem influ DNA CSF Ql NAA+probe

null

ACTIVE

2.72

99091-1

Listeria monocytogenes DNA

PrThr

Pt

CSF

Ord

Probe.amp.tar

MICRO

1

Listeria monocytogenes DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

L monocytog DNA CSF Ql NAA+probe

null

ACTIVE

2.72

99092-9

Neisseria meningitidis DNA

PrThr

Pt

CSF

Ord

Probe.amp.tar

MICRO

1

Neisseria meningitidis DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

N men DNA CSF Ql NAA+probe

null

ACTIVE

2.72

9909-3

P wave duration.lead V3

Time

Pt

Heart

Qn

EKG

EKG.MEAS

2

P wave duration in lead V3

P wave dur L-V3

null

ACTIVE

1.0i

2.48

99093-7

Streptococcus agalactiae DNA

PrThr

Pt

CSF

Ord

Probe.amp.tar

MICRO

1

Streptococcus agalactiae DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

Gp B Strep DNA CSF Ql NAA+probe

null

ACTIVE

2.72

99094-5

Streptococcus pneumoniae DNA

PrThr

Pt

CSF

Ord

Probe.amp.tar

MICRO

1

Streptococcus pneumoniae DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

S pneum DNA CSF Ql NAA+probe

null

ACTIVE

2.72

99095-2

Streptococcus pyogenes DNA

PrThr

Pt

CSF

Ord

Probe.amp.tar

MICRO

1

Streptococcus pyogenes DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

S pyo DNA CSF Ql NAA+probe

null

ACTIVE

2.72

99096-0

Mycoplasma pneumoniae DNA

PrThr

Pt

CSF

Ord

Probe.amp.tar

MICRO

1

Mycoplasma pneumoniae DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

M pneumo DNA CSF Ql NAA+probe

null

ACTIVE

2.72

99097-8

Blastomyces dermatitidis Ab.IgG

ACnc

Pt

CSF

Qn

IA

MICRO

1

Blastomyces dermatitidis IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

B dermat IgG CSF IA-aCnc

null

ACTIVE

2.72

99098-6

Blastomyces dermatitidis Ab.IgG

ACnc

Pt

Ser

Qn

IA

MICRO

1

Blastomyces dermatitidis IgG Ab [Units/volume] in Serum by Immunoassay

B dermat IgG Ser IA-aCnc

null

ACTIVE

2.72

99099-4

Procalcitonin

SCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Procalcitonin [Moles/volume] in Serum or Plasma

Procalcitonin SerPl-sCnc

null

ACTIVE

2.72

991-0

D little o super little a Ab

PrThr

Pt

Ser/Plas^BPU

Ord

null

BLDBK

1

Do sup(a) Ab [Presence] in Serum or Plasma from Blood product unit

Do sup(a) Ab SerPl BPU Ql

null

ACTIVE

1.0

2.56

99100-0

Norepinephrine

MCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Norepinephrine [Mass/volume] in Serum or Plasma

Norepineph SerPl-mCnc

null

ACTIVE

2.72

9910-1

P wave duration.lead V4

Time

Pt

Heart

Qn

EKG

EKG.MEAS

2

P wave duration in lead V4

P wave dur L-V4

null

ACTIVE

1.0i

2.48

99101-8

Cancer Ag 242

ACnc

Pt

Ser/Plas

Qn

null

CHEM

1

Cancer Ag 242 [Units/volume] in Serum or Plasma

Cancer Ag242 SerPl-aCnc

null

ACTIVE

2.72

99102-6

Gastrin releasing polypeptide

ACnc

Pt

Ser/Plas

Qn

null

CHEM

1

Gastrin releasing polypeptide [Units/volume] in Serum or Plasma

GRP SerPl-aCnc

null

ACTIVE

2.72

99103-4

Tumor necrosis factor.alpha

ACnc

Pt

Ser/Plas

Qn

null

CHEM

1

Tumor necrosis factor.alpha [Units/volume] in Serum or Plasma

A-Tumor Necrosis Fact SerPl-aCnc

null

ACTIVE

2.72

99104-2

Choriogonadotropin

MCnc

Pt

Urine

Qn

null

CHEM

1

Choriogonadotropin [Mass/volume] in Urine

HCG Ur-mCnc

null

ACTIVE

2.72

99105-9

Chlamydia trachomatis Ag

PrThr

Pt

Ser/Plas

Ord

IA

MICRO

1

Chlamydia trachomatis Ag [Presence] in Serum or Plasma by Immunoassay

C trach Ag SerPl Ql IA

null

ACTIVE

2.72

99106-7

How often do you attend meetings of the clubs or organizations you belong to

NRat

Pt

^Patient

Qn

null

SURVEY.NHANES

4

How often do you attend meetings of the clubs or organizations you belong to

null

ACTIVE

2.72

99107-5

Stimulants drug panel

-

Pt

Urine

-

Screen

PANEL.DRUG/TOX

1

Stimulants drug panel - Urine by Screen method

Stimulants drug panel Ur Scn

null

ACTIVE

2.72

99108-3

ePHEDrine

PrThr

Pt

Urine

Ord

Screen

DRUG/TOX

1

ePHEDrine [Presence] in Urine by Screen method

Ephedrin Ur Ql Scn

null

ACTIVE

2.72

99109-1

Pseudoephedrine

PrThr

Pt

Urine

Ord

Screen

DRUG/TOX

1

Pseudoephedrine [Presence] in Urine by Screen method

Pseudoephedrine Ur Ql Scn

null

ACTIVE

2.72

99110-9

Alpha-Phenyl-2-Piperidine acetate

PrThr

Pt

Urine

Ord

Screen

DRUG/TOX

1

Alpha-Phenyl-2-Piperidine acetate [Presence] in Urine by Screen method

PPAA Ur Ql Scn

null

ACTIVE

2.72

99111-7

Dengue virus Ab.Neut

Titr

Pt

XXX

Qn

Neut

MICRO

1

Dengue virus neutralizing antibody [Titer] in Specimen by Neutralization test

DENV NAb Titr Spec Nt

null

ACTIVE

2.72

99112-5

Rocio virus Ab.Neut

Titr

Pt

XXX

Qn

Neut

MICRO

1

Rocio virus neutralizing antibody [Titer] in Specimen by Neutralization test

Rocio virus NAb Titr Spec Nt

null

ACTIVE

2.72

99113-3

Ilheus virus Ab.Neut

Titr

Pt

XXX

Qn

Neut

MICRO

1

Ilheus virus neutralizing antibody [Titer] in Specimen by Neutralization test

ILHV NAb Titr Spec Nt

null

ACTIVE

2.72

99114-1

Semliki Forest virus Ab.Neut

Titr

Pt

XXX

Qn

Neut

MICRO

1

Semliki Forest virus neutralizing antibody [Titer] in Specimen by Neutralization test

SFV NAb Titr Spec Nt

null

ACTIVE

2.72

99115-8

Onyong-nyong virus Ab.Neut

Titr

Pt

XXX

Qn

Neut

MICRO

1

Onyong-nyong virus neutralizing antibody [Titer] in Specimen by Neutralization test

ONN virus NAb Titr Spec Nt

null

ACTIVE

2.72

99116-6

Bourbon virus Ab.Neut

Titr

Pt

XXX

Qn

Neut

MICRO

1

Bourbon virus neutralizing antibody [Titer] in Specimen by Neutralization test

Bourbon virus NAb Titr Spec Nt

null

ACTIVE

2.72

99117-4

Toscana virus Ab.Neut

Titr

Pt

XXX

Qn

Neut

MICRO

1

Toscana virus neutralizing antibody [Titer] in Specimen by Neutralization test

TOSV NAb Titr Spec Nt

null

ACTIVE

2.72

99118-2

Sandfly fever Sicilian virus Ab.Neut

Titr

Pt

XXX

Qn

Neut

MICRO

1

Sandfly fever Sicilian virus neutralizing antibody [Titer] in Specimen by Neutralization test

SFSV NAb Titr Spec Nt

null

ACTIVE

2.72

9911-9

P wave duration.lead V5

Time

Pt

Heart

Qn

EKG

EKG.MEAS

2

P wave duration in lead V5

P wave dur L-V5

null

ACTIVE

1.0i

2.48

99119-0

Sandfly fever Naples virus Ab.Neut

Titr

Pt

XXX

Qn

Neut

MICRO

1

Sandfly fever Naples virus neutralizing antibody [Titer] in Specimen by Neutralization test

SFNV NAb Titr Spec Nt

null

ACTIVE

2.72

99120-8

Oropouche virus Ab.Neut

Titr

Pt

XXX

Qn

Neut

MICRO

1

Oropouche virus neutralizing antibody [Titer] in Specimen by Neutralization test

Oropouche virus NAb Titr Spec Nt

null

ACTIVE

2.72

99121-6

Rift Valley fever virus Ab.Neut

Titr

Pt

XXX

Qn

Neut

MICRO

1

Rift valley fever virus neutralizing antibody [Titer] in Specimen by Neutralization test

RVFV NAb Titr Spec Nt

null

ACTIVE

2.72

99122-4

Bwamba virus Ab.Neut

Titr

Pt

XXX

Qn

Neut

MICRO

1

Bwamba virus neutralizing antibody [Titer] in Specimen by Neutralization test

Bwamba virus NAb Titr Spec Nt

null

ACTIVE

2.72

99123-2

Heartland banyangvirus Ab.Neut

Titr

Pt

XXX

Qn

Neut

MICRO

1

Heartland banyangvirus neutralizing antibody [Titer] in Specimen by Neutralization test

HRTV NAb Titr Spec Nt

null

ACTIVE

2.72

99124-0

Tick-borne encephalitis virus Ab.Neut

Titr

Pt

XXX

Qn

Neut

MICRO

1

Tick-borne encephalitis virus neutralizing antibody [Titer] in Specimen by Neutralization test

TBEV NAb Titr Spec Nt

null

ACTIVE

2.72

99125-7

Bunyamwera virus Ab.Neut

Titr

Pt

XXX

Qn

Neut

MICRO

1

Bunyamwera virus neutralizing antibody [Titer] in Specimen by Neutralization test

Bunyamwera virus NAb Titr Spec Nt

null

ACTIVE

2.72

99126-5

NOTCH1 gene targeted mutation analysis

Prid

Pt

Bld/Tiss

Nom

Molgen

MOLPATH.MUT

1

NOTCH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

NOTCH1 Mut Anl Bld/T

null

ACTIVE

2.72

9912-7

P wave duration.lead V6

Time

Pt

Heart

Qn

EKG

EKG.MEAS

2

P wave duration in lead V6

P wave dur L-V6

null

ACTIVE

1.0i

2.48

99127-3

BIRC3 gene targeted mutation analysis

Prid

Pt

Bld/Tiss

Nom

Molgen

MOLPATH.MUT

1

BIRC3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

BIRC3 gene Mut Anl Bld/T

null

ACTIVE

2.72

99128-1

PLCG2 gene targeted mutation analysis

Prid

Pt

Bld/Tiss

Nom

Molgen

MOLPATH.MUT

1

PLCG2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

PLCG2 gene Mut Anl Bld/T

null

ACTIVE

2.72

99129-9

SF3B1 gene targeted mutation analysis

Prid

Pt

Bld/Tiss

Nom

Molgen

MOLPATH.MUT

1

SF3B1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

SF3B1 gene Mut Anl Bld/T

null

ACTIVE

2.72

99130-7

Outcome and assessment information set (OASIS) form - version E

-

Pt

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

Outcome and assessment information set (OASIS) form - version E [CMS Assessment]

null

ACTIVE

2.72

99131-5

Outcome and assessment information set (OASIS) form - version E - Start of Care

-

Pt

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

Outcome and assessment information set (OASIS) form - version E - Start of Care [CMS Assessment]

null

ACTIVE

2.72

99132-3

OASIS E - Administrative information - SOC

-

Pt

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

OASIS E - Administrative information - SOC [CMS Assessment]

null

ACTIVE

2.72

99133-1

Near convergence break

InvLen

Pt

Eye

Qn

Phoropter

EYE.REFRACTION

2

Near convergence break by Phoropter

Near con break by Phoropter

null

ACTIVE

2.72

99134-9

You or your families' health is affected by environmental conditions at home

Find

Pt

^Patient

Ord

null

SURVEY.SDOH

4

You or your families' health is affected by environmental conditions at home

null

ACTIVE

2.72

9913-5

P' wave amplitude.lead AVF

Elpot

Pt

Heart

Qn

EKG

EKG.MEAS

2

P' wave amplitude in lead AVF

P' wave Amp L-AVF

null

ACTIVE

1.0i

2.48

99135-6

Environmental conditions in the home that affect you or your families' health

Find

Pt

^Patient

Nom

null

SURVEY.SDOH

4

Environmental conditions in the home that affect you or your families' health

null

ACTIVE

2.72

99136-4

Rabies virus Ab.IgM

Titr

Pt

XXX

Qn

IF

MICRO

1

Rabies virus IgM Ab [Titer] in Specimen by Immunofluorescence

RABV IgM Titr Spec IF

null

ACTIVE

2.72

99137-2

Rabies virus Ab.IgG

Titr

Pt

XXX

Qn

IF

MICRO

1

Rabies virus IgG Ab [Titer] in Specimen by Immunofluorescence

RABV IgG Titr Spec IF

null

ACTIVE

2.72

99138-0

OASIS E - Hearing, speech, and vision - SOC

-

Pt

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

OASIS E - Hearing, speech, and vision - SOC [CMS Assessment]

null

ACTIVE

2.72

99139-8

Sjogrens syndrome-A extractable nuclear 52kD Ab

ACnc

Pt

Ser

Qn

Line blot

SERO

1

Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum by Line blot

ENA SS-A 52kD Ab Ser Line blot-aCnc

null

ACTIVE

2.72

99140-6

OASIS E - Cognitive Patterns - SOC, ROC, DC

-

Pt

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

OASIS E - Cognitive Patterns - SOC, ROC, DC [CMS Assessment]

null

ACTIVE

2.72

99142-2

OASIS E - Health Conditions - SOC, ROC

-

Pt

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

OASIS E - Health Conditions - SOC, ROC [CMS Assessment]

null

ACTIVE

2.72

9914-3

P' wave amplitude.lead AVL

Elpot

Pt

Heart

Qn

EKG

EKG.MEAS

2

P' wave amplitude in lead AVL

P' wave Amp L-AVL

null

ACTIVE

1.0i

2.48

99143-0

OASIS E - Special Treatment, Procedures, and Programs - SOC

-

Pt

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

OASIS E - Special Treatment, Procedures, and Programs - SOC [CMS Assessment]

null

ACTIVE

2.72

99144-8

OASIS E - Behavior - SOC, ROC, DC

-

Pt

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

OASIS E - Behavior - SOC, ROC, DC [CMS Assessment]

null

ACTIVE

2.72

99146-3

OASIS E - Active Diagnoses - SOC

-

Pt

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

OASIS E - Active Diagnoses - SOC [CMS Assessment]

null

ACTIVE

2.72

99147-1

OASIS E - Preferences for Customary Routine Activities - SOC, ROC

-

Pt

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

OASIS E - Preferences for Customary Routine Activities - SOC, ROC [CMS Assessment]

null

ACTIVE

2.72

99148-9

OASIS E - Functional Status - SOC, ROC, DC

-

Pt

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

OASIS E - Functional Status - SOC, ROC, DC [CMS Assessment]

null

ACTIVE

2.72

99149-7

OASIS E - Self-care - follow-up performance

-

RptPeriod

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

OASIS E - Self-care - follow-up performance during assessment period [CMS Assessment]

null

ACTIVE

2.72

9915-0

P' wave amplitude.lead AVR

Elpot

Pt

Heart

Qn

EKG

EKG.MEAS

2

P' wave amplitude in lead AVR

P' wave Amp L-AVR

null

ACTIVE

1.0i

2.48

99150-5

OASIS E - Mobility - follow-up performance

-

RptPeriod

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

OASIS E - Mobility - follow-up performance during assessment period [CMS Assessment]

null

ACTIVE

2.72

99151-3

OASIS E - Medications - SOC, ROC

-

Pt

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

OASIS E - Medications - SOC, ROC [CMS Assessment]

null

ACTIVE

2.72

99152-1

OASIS E - Swallowing And Or Nutritional Status - SOC

-

Pt

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

OASIS E - Swallowing And Or Nutritional Status - SOC [CMS Assessment]

null

ACTIVE

2.72

99153-9

Outcome and assessment information set (OASIS) form - version E - Follow Up

-

Pt

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

Outcome and assessment information set (OASIS) form - version E - Follow Up [CMS Assessment]

null

ACTIVE

2.72

99154-7

OASIS E - Functional abilities and goals - FU

-

Pt

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

OASIS E - Functional abilities and goals - FU [CMS Assessment]

null

ACTIVE

2.72

99155-4

OASIS E - Functional Status - follow up

-

Pt

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

OASIS E - Functional Status - follow up [CMS Assessment]

null

ACTIVE

2.72

99156-2

OASIS E - Health Conditions - FU

-

Pt

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

OASIS E - Health Conditions - FU [CMS Assessment]

null

ACTIVE

2.72

99157-0

OASIS E - Skin Conditions - FU

-

Pt

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

OASIS E - Skin Conditions - FU [CMS Assessment]

null

ACTIVE

2.72

99158-8

Outcome and assessment information set (OASIS) form - version E - Death at Home

-

Pt

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

Outcome and assessment information set (OASIS) form - version E - Death at Home [CMS Assessment]

null

ACTIVE

2.72

99159-6

OASIS E - Administrative information - DAH

-

Pt

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

OASIS E - Administrative information - DAH [CMS Assessment]

null

ACTIVE

2.72

99160-4

Outcome and assessment information set (OASIS) form - version E - Resumption of Care

-

Pt

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

Outcome and assessment information set (OASIS) form - version E - Resumption of Care [CMS Assessment]

null

ACTIVE

2.72

99161-2

OASIS E - Administrative information - ROC

-

Pt

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

OASIS E - Administrative information - ROC [CMS Assessment]

null

ACTIVE

2.72

9916-8

P' wave amplitude.lead I

Elpot

Pt

Heart

Qn

EKG

EKG.MEAS

2

P' wave amplitude in lead I

P' wave Amp L-I

null

ACTIVE

1.0i

2.48

99169-5

OASIS E - Active Diagnoses - ROC

-

Pt

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

OASIS E - Active Diagnoses - ROC [CMS Assessment]

null

ACTIVE

2.72